Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

No papers, no care: Disabled migrants seek help through lawsuit, activism

Desperation led José Luis Hernández to ride atop a speeding train through northern Mexico with hopes of reaching the United States 13 years ago.

16 Sep 2021

Rockefeller saliva test turns out to be easier and safer to administer than conventional COVID tests

In the early days of the pandemic, with commercial COVID tests in short supply, Rockefeller's Robert B. Darnell developed an in-house assay to identify positive cases within the Rockefeller community.

16 Sep 2021

New modeling on efficacy of BioNTech-Pfizer's SARS-CoV-2 vaccine against variants

In order to address these issues, scientists from Xitific LTD and IDEAPharma in the UK proposed a novel approach to the framework of immune correlates, built upon the previous research. The framework formulated by the authors was developed for the mRNA-based vaccinations but could be applied to the other variations.

16 Sep 2021

Reframing the understanding of stress can make a big difference to students' wellbeing, success

Sweaty palms during a job interview. Racing heartbeat before the walk down the aisle. Stomach pains ahead of a final exam. Many of us have experienced a classic stress response in new, unusual, or high-pressure circumstances.

16 Sep 2021

Therapeutic potential of clinical-grade ACE2 for blocking SARS-CoV-2 variants

According to new research by an international team of scientists, all SARS-CoV-2 variants, including variants of concern (VOC) Alpha, Beta, Gamma, and Delta, exhibit enhanced affinity toward recombinant human soluble ACE2.

16 Sep 2021

Scientists develop predictive computer model to alert surges in COVID-19 infections and mortalities

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a predictive computer model that, when tested on real pandemic data, proposed strategies that would have reduced the rate of both COVID-19 infections and deaths by an average of 72 percent, based on a sample from four countries.

16 Sep 2021

Multiple factors influence the extent to which African countries are affected by Covid-19, study shows

Countries in Africa assessed as being least vulnerable to an epidemic were the worst affected by Covid-19, new research suggests.

16 Sep 2021

This 3D modeling reveals how SARS-CoV-2 attacks

Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.

16 Sep 2021

Grants to promote COVID-19 vaccination among people with intellectual and developmental disabilities

Patients with intellectual and developmental disabilities (IDD) are three times more likely to die from COVID-19 than the general population. Their heightened risk is due to a variety of causes: pre-existing health conditions, such as respiratory problems or obesity; increased likelihood of living in group homes, taking shared transportation, and being exposed to people outside their households; and struggles with safety precautions like mask-wearing or social distancing.

16 Sep 2021

Pfizer-BioNTech’s COVID-19 vaccine proves effective against recent SARS-CoV-2 variants

Researchers in the United States and Germany have conducted a study showing that the Pfizer-BioNTech vaccine designed to protect against coronavirus disease 2019 (COVID-19) is effective against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2).

16 Sep 2021

German chancellor delighted after company visit to KNAUER, calling the company a pearl

German Chancellor Dr. Angela Merkel visited Berlin-based manufacturer of high-tech laboratory instruments KNAUER Wissenschaftliche Geräte GmbH on Friday, Sept. 10, 2021.

From KNAUER Wissenschaftliche Geräte GmbH 16 Sep 2021

COVID-19 pandemic may have made women think twice about expanding their families, study shows

Nearly half of New York City mothers who had been trying to become pregnant before the coronavirus pandemic began stopped in the first few months of the outbreak, a new study shows.

15 Sep 2021

NYU Langone completes study designs for NIH research initiative on long-term impact of COVID-19

NYU Langone Health, as the Clinical Science Core for the National Institutes of Health's RECOVER initiative, has, since the announcement of the beginning of its operations on June 10, convened more than 100 researchers from 35 institutions as well as patients to finalize the main study protocols for the adult, pediatric, and autopsy patient groups (cohorts).

15 Sep 2021

Pandemic News and Research

Further Reading

No papers, no care: Disabled migrants seek help through lawsuit, activism

Rockefeller saliva test turns out to be easier and safer to administer than conventional COVID tests

New modeling on efficacy of BioNTech-Pfizer's SARS-CoV-2 vaccine against variants

Reframing the understanding of stress can make a big difference to students' wellbeing, success

Therapeutic potential of clinical-grade ACE2 for blocking SARS-CoV-2 variants

Scientists develop predictive computer model to alert surges in COVID-19 infections and mortalities

Multiple factors influence the extent to which African countries are affected by Covid-19, study shows

This 3D modeling reveals how SARS-CoV-2 attacks

Grants to promote COVID-19 vaccination among people with intellectual and developmental disabilities

Pfizer-BioNTech’s COVID-19 vaccine proves effective against recent SARS-CoV-2 variants

German chancellor delighted after company visit to KNAUER, calling the company a pearl

COVID-19 pandemic may have made women think twice about expanding their families, study shows

NYU Langone completes study designs for NIH research initiative on long-term impact of COVID-19

Study identifies factors associated with COVID-19 disease severity in children

Analysis of the immune landscape in mild-to-moderate COVID-19

Pew announces support for the 2021 class of Innovation Fund investigators

For My Lung Health campaign wins 2021 Pharmaceutical Executive APEX Awards

COVID mRNA vaccines display weakened immune response with age and diminish over time, according to new study

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Hospitals use artificial intelligence to predict Covid patients’ oxygen needs

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News